Safety and Effectiveness of D-serine in Schizophrenia
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study will determine whether increasing D-serine within the body will improve negative
symptoms and cognitive impairments in people with schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Nathan Kline Institute for Psychiatric Research National Institute of Mental Health (NIMH)